Interestingly, miR-126 and miR-126* target SDF-1α to suppress breast cancer metastasis through the inhibition of the recruitment of mesenchymal stem cells and inflammatory monocytes [84]. This evidence concerns the gene CXCL12 and breast carcinoma.